These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10219738)

  • 1. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.
    Everall IP; Heaton RK; Marcotte TD; Ellis RJ; McCutchan JA; Atkinson JH; Grant I; Mallory M; Masliah E
    Brain Pathol; 1999 Apr; 9(2):209-17. PubMed ID: 10219738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders.
    Cherner M; Cysique L; Heaton RK; Marcotte TD; Ellis RJ; Masliah E; Grant I;
    J Neurovirol; 2007; 13(1):23-8. PubMed ID: 17454445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center.
    Masliah E; Heaton RK; Marcotte TD; Ellis RJ; Wiley CA; Mallory M; Achim CL; McCutchan JA; Nelson JA; Atkinson JH; Grant I
    Ann Neurol; 1997 Dec; 42(6):963-72. PubMed ID: 9403489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Interleukin-1β by Human Immunodeficiency Virus-1 Viral Proteins Leads to Increased Levels of Neuronal Ferritin Heavy Chain, Synaptic Injury, and Deficits in Flexible Attention.
    Festa L; Gutoskey CJ; Graziano A; Waterhouse BD; Meucci O
    J Neurosci; 2015 Jul; 35(29):10550-61. PubMed ID: 26203149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of human immunodeficiency virus-associated neocortical damage.
    Masliah E; Achim CL; Ge N; DeTeresa R; Terry RD; Wiley CA
    Ann Neurol; 1992 Sep; 32(3):321-9. PubMed ID: 1416802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive disorders in HIV-1 infection. HNRC Group. HIV Neurobehavioral Research Center.
    Grant I; Heaton RK; Atkinson JH
    Curr Top Microbiol Immunol; 1995; 202():11-32. PubMed ID: 7587358
    [No Abstract]   [Full Text] [Related]  

  • 7. Human immunodeficiency virus-related cognitive impairment and the acquired immunodeficiency syndrome dementia complex.
    Robertson KR; Hall CD
    Semin Neurol; 1992 Mar; 12(1):18-27. PubMed ID: 1615236
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study.
    Weis S; Haug H; Budka H
    Acta Neuropathol; 1993; 85(2):185-9. PubMed ID: 8442409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.
    Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK;
    AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological investigation of patients with AIDS and ARC.
    Perdices M; Cooper DA
    J Acquir Immune Defic Syndr (1988); 1990; 3(6):555-64. PubMed ID: 2338617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.
    Gelman BB; Lisinicchia JG; Chen T; Johnson KM; Jennings K; Freeman DH; Soukup VM
    J Neuroimmune Pharmacol; 2012 Sep; 7(3):686-700. PubMed ID: 22391864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients.
    Bell JE; Donaldson YK; Lowrie S; McKenzie CA; Elton RA; Chiswick A; Brettle RP; Ironside JW; Simmonds P
    AIDS; 1996 May; 10(5):493-9. PubMed ID: 8724040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex.
    Maingat F; Vivithanaporn P; Zhu Y; Taylor A; Baker G; Pearson K; Power C
    J Neurosci; 2009 Jul; 29(26):8429-37. PubMed ID: 19571133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.
    Kim HJ; Martemyanov KA; Thayer SA
    J Neurosci; 2008 Nov; 28(48):12604-13. PubMed ID: 19036954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of the central nervous system in acquired immune deficiency syndrome (AIDS) in Japan. With special reference to human immunodeficiency virus-induced encephalomyelopathies.
    Funata N; Maeda Y; Koike M; Okeda R
    Acta Pathol Jpn; 1991 Mar; 41(3):206-11. PubMed ID: 2068945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.
    Cherner M; Masliah E; Ellis RJ; Marcotte TD; Moore DJ; Grant I; Heaton RK
    Neurology; 2002 Nov; 59(10):1563-7. PubMed ID: 12451198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of selective neuronal damage in methamphetamine-user AIDS patients.
    Langford D; Adame A; Grigorian A; Grant I; McCutchan JA; Ellis RJ; Marcotte TD; Masliah E;
    J Acquir Immune Defic Syndr; 2003 Dec; 34(5):467-74. PubMed ID: 14657756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.
    Cysique LA; Maruff P; Brew BJ
    J Neurovirol; 2004 Dec; 10(6):350-7. PubMed ID: 15765806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in HIV infection.
    Krikorian R; Wrobel AJ
    AIDS; 1991 Dec; 5(12):1501-7. PubMed ID: 1814332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
    Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
    Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.